|
Transfusion in the New Millennium |
|
|
1 | (13) |
|
|
|
|
| SECTION I: Blood Components and Derivatives |
|
| PART I: Red Blood Cell |
|
|
Red Blood Cell Production and Kinetics |
|
|
14 | (11) |
|
|
|
Hemoglobin Synthesis, Structure and Oxygen Transport |
|
|
25 | (18) |
|
|
|
Red Blood Cell Metabolism |
|
|
43 | (7) |
|
|
|
Liquid Preservation of Red Blood Cells |
|
|
50 | (12) |
|
|
|
Frozen Preservation of Red Blood Cells |
|
|
62 | (7) |
|
|
|
Red Blood Cell Immunology and Compatibility Testing |
|
|
69 | (23) |
|
|
|
Case 7A. Knowing When To Ask for Help |
|
|
89 | (3) |
|
|
|
Human Carbohydrate Blood Group Systems |
|
|
92 | (21) |
|
|
|
|
|
Case 8A. A French Canadian with a Rare Blood Type |
|
|
111 | (2) |
|
|
|
Rh and LW Blood Group Systems |
|
|
113 | (12) |
|
|
|
|
|
|
|
123 | (2) |
|
|
|
Other Protein Blood Group Antigens |
|
|
125 | (13) |
|
|
|
Case 10A. The Awful Allos: Managing the Patient with Multiple Alloantibodies |
|
|
135 | (3) |
|
|
|
Erythrocytosis and Therapeutic Phlebotomy |
|
|
138 | (11) |
|
|
|
Anemia and Red Blood Cell Transfusion |
|
|
149 | (16) |
|
|
|
|
|
Red Blood Cell Substitutes |
|
|
165 | (12) |
|
|
| PART II: Platelets |
|
|
Megakaryocytopoiesis, Kinetics, and Radiolabeling |
|
|
177 | (15) |
|
|
|
S. Platelet Kinetics and Hemostasis |
|
|
192 | (11) |
|
|
|
Platelet Immunology and Alloimmunization |
|
|
203 | (17) |
|
|
|
|
|
|
|
Case 16A. If at First You Don't Succeed, Sometimes You Should Not Try Again |
|
|
218 | (2) |
|
|
|
Preparation and Storage of Platelet Concentrates |
|
|
220 | (12) |
|
|
|
Platelet Transfusion and Alternatives |
|
|
232 | (18) |
|
|
|
|
|
|
|
Case 18A. Interconnected Cascades |
|
|
248 | (2) |
|
|
| PART III: White Blood Cell |
|
|
Neutrophil Production and Kinetics: Neutropenia and Neutrophilia |
|
|
250 | (8) |
|
|
|
Neutrophil Collection and Transfusion |
|
|
258 | (12) |
|
|
|
Case 20A. Is G-CSF Leukemogenic? |
|
|
268 | (2) |
|
|
|
Leukoreduced Blood Components: Laboratory and Clinical Aspects |
|
|
270 | (18) |
|
|
| PART IV: Plasma |
|
|
Plasma Composition and Coagulation Mechanism |
|
|
288 | (16) |
|
|
|
|
|
Preparation of Plasma Derivatives |
|
|
304 | (12) |
|
|
|
Immunoglobins in Clinical Medicine |
|
|
316 | (19) |
|
|
|
|
|
Case 24A. Unexpected Thrombocytopenia Before Surgery |
|
|
333 | (2) |
|
|
|
|
|
Plasma Transfusion and Alternatives |
|
|
335 | (10) |
|
|
|
Case 25A. Danger in Treating the Numbers |
|
|
341 | (4) |
|
|
| SECTION II: Clinical Practice |
|
| PART I: Medical Patient |
|
|
Autoimmune Hemolytic Anemia and Paroxysmal Nocturnal Hemoglobinuria |
|
|
345 | (22) |
|
|
|
Management of Immune Thrombocytopenia |
|
|
367 | (32) |
|
|
|
Case 27A. A Diagnosis You Don't Want to Miss |
|
|
396 | (3) |
|
|
|
Bleeding from Acquired Coagulation Defects and Antithrombotic Therapy |
|
|
399 | (18) |
|
|
|
|
|
|
|
Case 28A. It Seemed Like a Magic Potion |
|
|
415 | (2) |
|
|
| PART II: Pediatric, Obstetric, Congenital |
|
|
Fetal and Neonatal Hematopoiesis |
|
|
417 | (11) |
|
|
|
|
|
Hemolytic Disease of the Fetus or Newborn: Treatment and Prevention |
|
|
428 | (20) |
|
|
|
|
|
Case 30A. New Treatment for an Old Problem |
|
|
446 | (2) |
|
|
|
Congenital Disorders of Clotting Proteins and their Management |
|
|
448 | (15) |
|
|
|
Management of Congenital Hemolytic Anemias |
|
|
463 | (23) |
|
|
|
|
|
Case 32A. A Delayed Hemolytic Transfusion Reaction Run Amok |
|
|
483 | (3) |
|
|
|
Neonatal Red Blood Cell, Platelet, Plasma, and Neutrophil Transfusions |
|
|
486 | (12) |
|
|
| PART III: Oncology Patients |
|
|
Transfusion Support for the Oncology Patient |
|
|
498 | (15) |
|
|
|
Case 34A. First Things First |
|
|
511 | (2) |
|
|
|
Hematopoietic Growth Factors (Cytokines) |
|
|
513 | (9) |
|
|
|
|
|
|
|
Processing and Preservation of Hematopoietic Progenitor Cells |
|
|
522 | (15) |
|
|
|
|
|
|
|
534 | (3) |
|
|
|
|
|
|
|
Human Progenitor Cell-Autologous Transplantation |
|
|
537 | (18) |
|
|
|
|
|
Blood and Marrow Transplantation |
|
|
555 | (18) |
|
|
|
|
|
|
|
|
|
Case 38A. Break on Through to the Other Side |
|
|
570 | (3) |
|
|
|
|
|
|
|
573 | (7) |
|
|
|
Gene Therapy in Transfusion Medicine |
|
|
580 | (10) |
|
|
| PART IV: Surgery Patients |
|
|
Red Blood Cell Support in the Perioperative Setting |
|
|
590 | (12) |
|
|
|
Coagulation Support in the Perioperative Setting |
|
|
602 | (20) |
|
|
|
|
|
Transfusion Therapy in Solid-Organ Transplantation |
|
|
622 | (10) |
|
|
|
Transfusion Therapy in the Care of Trauma and Burn Patients |
|
|
632 | (16) |
|
|
|
|
|
Case 44A. Emergency Transfusion |
|
|
644 | (4) |
|
|
| SECTION III: Apheresis |
|
|
Apheresis: Principles and Technology of Hemapheresis |
|
|
648 | (14) |
|
|
|
Case 45A. A Call One Saturday Morning |
|
|
659 | (3) |
|
Zbigniew M. Szczepiorkowski |
|
|
Therapeutic Plasma Exchange |
|
|
662 | (23) |
|
|
|
Case 46A. What's Your Diagnosis? |
|
|
683 | (2) |
|
|
|
|
|
Specialized Therapeutic Hemapheresis Procedures |
|
|
685 | (18) |
|
|
|
|
|
Case 47A. Too Much Dust in the Blood |
|
|
699 | (4) |
|
|
| SECTION IV: Adverse Sequelae |
|
| PART I: Disease Transmission |
|
|
Transfusion-Transmitted Infection Risk from Blood Components and Plasma Derivatives |
|
|
703 | (15) |
|
|
|
Transfusion-Transmitted Hepatitis C and Non A, Non B, Non C Virus Infections |
|
|
718 | (15) |
|
|
|
Transfusion-Transmitted Hepatitis B, A, and D |
|
|
733 | (9) |
|
|
|
|
|
742 | (15) |
|
|
|
|
|
Cytomegalovirus and Parvovirus Transmission Transfusion |
|
|
757 | (17) |
|
|
|
|
|
Case 52A. CMV Infection in an Immunosuppressed Infant |
|
|
772 | (2) |
|
|
|
Transmission of Parasitic Infections by Blood Transfusion |
|
|
774 | (10) |
|
|
|
|
|
Case 53A. Fever after Blood Transfusion |
|
|
782 | (2) |
|
|
|
|
|
Transmission of Creutzfeldt-Jakob Disease by Transfusion |
|
|
784 | (5) |
|
|
|
Bacterial Contamination of Blood Products |
|
|
789 | (17) |
|
|
|
Case 55A. It Ain't Over 'Till It's Over |
|
|
802 | (4) |
|
|
|
|
|
Pathogen Inactivation in Blood Components |
|
|
806 | (9) |
|
|
| PART II: Transfusion Reactions |
|
|
Hemolytic Transfusion Reactions |
|
|
815 | (16) |
|
|
|
Case 57A. A Hemolytic Transfusion Reaction: Doing it the Hard Way |
|
|
829 | (2) |
|
|
|
Febrile, Allergic, and Non-Immune Transfusion Reactions |
|
|
831 | (21) |
|
|
|
|
|
Transfusion-Associated Graft Versus Host Disease |
|
|
852 | (15) |
|
|
|
|
|
Case 59A. `O'h It's Back `A'-gain |
|
|
865 | (2) |
|
|
|
|
|
Transfusion-Associated Immunomodulation |
|
|
867 | (12) |
|
|
|
|
| SECTION V: Special Topics |
|
|
Red Blood Cell Radiolabeling and In Vivo Kinetics |
|
|
879 | (7) |
|
|
|
HLA and Molecular Testing |
|
|
886 | (12) |
|
|
|
|
|
898 | (14) |
|
|
|
|
|
912 | (15) |
|
|
|
Medicolegal Aspects of Blood Transfusion |
|
|
927 | (17) |
|
|
|
|
|
Case 65A. Elective Surgery in a Jehovah's Witness |
|
|
940 | (4) |
|
|
| SECTION VI: Delivery of Blood Services |
|
|
Organization of Blood Services in the United States |
|
|
944 | (9) |
|
|
|
International Aspects of Blood Services |
|
|
953 | (5) |
|
|
|
Current Good Manufacturing Practices |
|
|
958 | (14) |
|
|
|
|
|
Hospital Transfusion Services and Quality Assurance |
|
|
972 | |
|
|